Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Genet Med ; 19(4): 448-456, 2017 04.
Artigo em Inglês | MEDLINE | ID: mdl-27684037

RESUMO

PURPOSE: Increasingly, women newly diagnosed with breast cancer are being offered treatment-focused genetic testing (TFGT). As the demand for TFGT increases, streamlined methods of genetic education are needed. METHODS: In this noninferiority trial, women aged <50 years with either a strong family history (FH+) or other features suggestive of a germ-line mutation (FH-) were randomized before definitive breast cancer surgery to receive TFGT education either as brief written materials (intervention group (IG)) or during a genetic counseling session at a familial cancer clinic (usual-care group (UCG)). Women completed self-report questionnaires at four time points over 12 months. RESULTS: A total of 135 women were included in the analysis, all of whom opted for TFGT. Decisional conflict about TFGT choice (primary outcome) was not inferior in the IG compared with the UCG (noninferiority margin of -10; mean difference = 2.45; 95% confidence interval -2.87-7.76; P = 0.36). Costs per woman counseled in the IG were significantly lower (AUD$89) compared with the UCG (AUD$173; t(115) = 6.02; P < 0.001). CONCLUSION: A streamlined model of educating women newly diagnosed with breast cancer about TFGT seems to be a cost-effective way of delivering education while ensuring that women feel informed and supported in their decision making, thus freeing resources for other women to access TFGT.Genet Med 19 4, 448-456.


Assuntos
Neoplasias da Mama/genética , Aconselhamento Genético/economia , Adolescente , Adulto , Proteína BRCA1/genética , Proteína BRCA2/genética , Neoplasias da Mama/terapia , Análise Custo-Benefício , Tomada de Decisões , Feminino , Aconselhamento Genético/métodos , Testes Genéticos , Mutação em Linhagem Germinativa , Humanos , Pessoa de Meia-Idade , Autorrelato , Adulto Jovem
2.
Ann Diagn Pathol ; 16(6): 485-8, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-21684182

RESUMO

This is the first reported case of a sebaceous adenoma arising within an ovarian mature cystic teratoma in a patient with Muir-Torre syndrome. The pathologic findings and a literature review are presented, including the importance and possible benefits of an early diagnosis of Muir-Torre syndrome. It is proposed that the presence of a sebaceous adenoma in an ovarian cystic teratoma may serve as a useful trigger to consider further history and investigations, with the goal of identifying an important genetic cancer predisposition syndrome.


Assuntos
Adenocarcinoma Sebáceo/complicações , Síndrome de Muir-Torre/complicações , Cistos Ovarianos/complicações , Neoplasias Ovarianas/complicações , Teratoma/complicações , Adenocarcinoma Sebáceo/patologia , Adenocarcinoma Sebáceo/cirurgia , Biópsia , Diagnóstico Diferencial , Feminino , Predisposição Genética para Doença , Humanos , Pessoa de Meia-Idade , Síndrome de Muir-Torre/patologia , Síndrome de Muir-Torre/cirurgia , Proteína 2 Homóloga a MutS/genética , Mutação , Cistos Ovarianos/patologia , Cistos Ovarianos/cirurgia , Neoplasias Ovarianas/patologia , Neoplasias Ovarianas/cirurgia , Teratoma/patologia , Teratoma/cirurgia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA